Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium

2010356 citationsJournal Article

Authors

James F. Donohue · University of North Carolina at Chapel Hill

Charles Fogarty · Spartanburg Regional Medical Center

Jan Lötvall · University of Gothenburg

Donald A. Mahler · Dartmouth College

H. Worth · Kliniken der Stadt Köln

Arzu Yorgancıoğlu · Manisa Celal Bayar University

Amir Iqbal

Abstract

Indacaterol was an effective once-daily bronchodilator and was at least as effective as tiotropium in improving clinical outcomes for patients with COPD. Clinical trial registered with clinicaltrials.gov (NCT 00463567).

Topics & Keywords

Chronic Obstructive Pulmonary Disease (COPD) Research Asthma and respiratory diseases Respiratory Support and Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Respiratory and Critical Care Medicine

Volume 182, Issue 2, pp. 155-162

DOI: 10.1164/rccm.200910-1500oc

Field-Weighted Citation Impact: 40.16